Longboard Pharmaceuticals (LBPH) Short Interest Ratio & Short Volume → This Weight Loss Company Can't Make Enough Product (From Behind the Markets) (Ad) Free LBPH Stock Alerts $18.90 +0.07 (+0.37%) (As of 12:59 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Longboard Pharmaceuticals Short Interest DataCurrent Short Interest3,925,700 sharesPrevious Short Interest4,220,000 sharesChange Vs. Previous Month-6.97%Dollar Volume Sold Short$74.08 millionShort Interest Ratio10.2 Days to CoverLast Record DateMay 31, 2024Outstanding Shares38,880,000 sharesFloat Size32,862,100 sharesShort Percent of Float11.95%Today's Trading Volume53,060 sharesAverage Trading Volume955,621 sharesToday's Volume Vs. Average6% Short Selling Longboard Pharmaceuticals ? Sign up to receive the latest short interest report for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLBPH Short Interest Over TimeLBPH Days to Cover Over TimeLBPH Percentage of Float Shorted Over Time Ad Prosper Trading AcademyBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)Click Here To Read More About This Game Changing AI Tool Longboard Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20243,925,700 shares $74.08 million -7.0%12.0%10.2 $18.87 5/15/20244,220,000 shares $89.21 million -2.5%12.8%10.4 $21.14 4/30/20244,330,000 shares $92.23 million -12.0%13.0%8.6 $21.30 4/15/20244,920,000 shares $89.79 million -0.6%14.8%8.3 $18.25 3/31/20244,950,000 shares $106.92 million +32.4%14.9%7.7 $21.60 3/15/20243,740,000 shares $72.26 million +17.2%11.3%2.6 $19.32 Get the Latest News and Ratings for LBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/29/20243,190,000 shares $70.75 million +0.3%9.9%2.3 $22.18 2/15/20243,180,000 shares $66.27 million +30.3%9.8%2.4 $20.84 1/31/20242,440,000 shares $51.83 million +43.5%7.9%2 $21.24 1/15/20241,700,000 shares $39.87 million +138.8%9.9%1.6 $23.45 12/31/2023711,800 shares $4.29 million +22.5%4.2%0.7 $6.03 12/15/2023581,200 shares $2.92 million +13.3%3.4%7.7 $5.02 11/30/2023512,800 shares $1.93 million +8.1%2.9%9.7 $3.76 11/15/2023474,400 shares $2.32 million -3.0%2.7%10.2 $4.88 10/31/2023488,800 shares $2.65 million -2.0%2.9%10.5 $5.42 10/15/2023498,500 shares $2.51 million -8.7%3.0%8.1 $5.03 9/30/2023546,200 shares $3.04 million -4.1%3.3%8.6 $5.56 9/15/2023569,600 shares $3.55 million -10.1%3.1%8.3 $6.23 8/31/2023633,900 shares $3.67 million -4.0%3.5%5.8 $5.79 8/15/2023660,300 shares $4.26 million +0.4%3.6%5.9 $6.45 7/31/2023657,800 shares $4.74 million -7.9%4.2%5.3 $7.20 7/15/2023714,400 shares $4.74 million -2.5%5.1%5.7 $6.64 6/30/2023732,800 shares $5.38 million +165.2%5.2%5.4 $7.34 6/15/2023276,300 shares $2.14 million +36.5%2.0%2.1 $7.76 5/31/2023202,400 shares $1.40 million +149.9%1.4%2.2 $6.93 5/15/202381,000 shares $718,470.00 +352.5%0.6%1 $8.87 4/30/202317,900 shares $148,212.00 +23.5%0.1%0.3 $8.28 4/15/202314,500 shares $88,160.00 +93.3%0.1%0.3 $6.08 3/31/20237,500 shares $30,075.00 -27.2%0.1%0.2 $4.01 3/15/202310,300 shares $49,337.00 -16.3%0.1%0.4 $4.79 2/28/202312,300 shares $62,238.00 -9.6%0.1%0.5 $5.06 2/15/202313,600 shares $67,864.00 -24.9%0.2%0.5 $4.99 1/31/202318,100 shares $77,106.00 +1.1%0.2%0.8 $4.26 1/15/202317,900 shares $105,699.50 +25.2%0.2%0.8 $5.91 12/30/202214,300 shares $46,618.00 -18.3%0.2%0.7 $3.26 12/15/202217,500 shares $70,350.00 -45.1%0.2%0.9 $4.02 11/30/202231,900 shares $171,303.00 -33.5%0.4%1.5 $5.37 11/15/202248,000 shares $227,520.00 +21.5%0.5%2.3 $4.74 10/31/202239,500 shares $146,150.00 -13.6%0.4%1.4 $3.70 10/15/202245,700 shares $150,810.00 -9.5%0.5%2.1 $3.30This Weight Loss Company Can't Make Enough Product (Ad)A tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> 9/30/202250,500 shares $187,860.00 +9.3%0.6%2.3 $3.72 9/15/202246,200 shares $198,660.00 +94.1%0.5%2.1 $4.30 8/31/202223,800 shares $79,730.00 -24.2%0.3%1.2 $3.35 8/15/202231,400 shares $133,921.00 -34.3%0.3%2 $4.27 7/31/202247,800 shares $160,608.00 +9.9%0.5%6.7 $3.36 7/15/202243,500 shares $143,115.00 -11.6%0.5%6.2 $3.29 6/30/202249,200 shares $152,028.00 -12.1%0.5%5.2 $3.09 6/15/202256,000 shares $235,200.00 -18.4%0.6%6.4 $4.20 5/31/202268,600 shares $352,604.00 +11.5%0.8%6.5 $5.14 5/15/202261,500 shares $276,750.00 -16.7%0.7%5.4 $4.50 4/30/202273,800 shares $356,653.26 -14.2%0.8%5.3 $4.83 4/15/202286,000 shares $429,140.00 -3.2%0.9%5.5 $4.99 3/31/202288,800 shares $474,192.00 +8.3%1.0%4.6 $5.34 3/15/202282,000 shares $415,740.00 -10.6%0.9%2.5 $5.07 2/28/202291,700 shares $420,903.00 -4.1%1.0%2.6 $4.59 2/15/202295,600 shares $477,044.00 +21.6%1.0%2.8 $4.99 1/31/202278,600 shares $330,120.00 -22.8%0.9%2.2 $4.20 1/15/2022101,800 shares $433,668.00 -4.9%1.1%2.4 $4.26 12/31/2021107,000 shares $522,160.00 +47.4%1.2%2.4 $4.88 12/15/202172,600 shares $431,970.00 +9.7%0.8%2.1 $5.95 11/30/202166,200 shares $370,389.00 -3.8%0.7%2.3 $5.60 11/15/202168,800 shares $427,248.00 +44.5%0.8%2.3 $6.21 10/29/202147,600 shares $354,620.00 -25.0%0.5%1.5 $7.45 10/15/202163,500 shares $562,610.00 -12.5%0.7%2.3 $8.86 9/30/202172,600 shares $642,510.00 -9.3%0.8%1.4 $8.85 9/15/202180,000 shares $736,000.00 -9.8%0.9%1.5 $9.20 8/31/202188,700 shares $832,006.00 +25.3%1.0%1.5 $9.38 8/13/202170,800 shares $652,776.00 No Change0.8%1.1 $9.22 LBPH Short Interest - Frequently Asked Questions What is Longboard Pharmaceuticals' current short interest? Short interest is the volume of Longboard Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 3,925,700 shares of LBPH short. 11.95% of Longboard Pharmaceuticals' shares are currently sold short. Learn More on Longboard Pharmaceuticals' current short interest. What is a good short interest ratio for Longboard Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LBPH shares currently have a short interest ratio of 10.0. Learn More on Longboard Pharmaceuticals's short interest ratio. What is a good short interest percentage for Longboard Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.95% of Longboard Pharmaceuticals' floating shares are currently sold short. Is Longboard Pharmaceuticals' short interest increasing or decreasing? Longboard Pharmaceuticals saw a decline in short interest in May. As of May 31st, there was short interest totaling 3,925,700 shares, a decline of 7.0% from the previous total of 4,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Longboard Pharmaceuticals' float size? Longboard Pharmaceuticals currently has issued a total of 38,880,000 shares. Some of Longboard Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Longboard Pharmaceuticals currently has a public float of 32,862,100 shares. How does Longboard Pharmaceuticals' short interest compare to its competitors? 11.95% of Longboard Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Longboard Pharmaceuticals: Societal CDMO, Inc. (0.00%), PTC Therapeutics, Inc. (9.77%), Xenon Pharmaceuticals Inc. (3.96%), IDEAYA Biosciences, Inc. (15.88%), MorphoSys AG (0.56%), MoonLake Immunotherapeutics (15.03%), Avidity Biosciences, Inc. (11.31%), Dyne Therapeutics, Inc. (11.57%), Agios Pharmaceuticals, Inc. (8.07%), TG Therapeutics, Inc. (24.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Longboard Pharmaceuticals stock? Short selling LBPH is an investing strategy that aims to generate trading profit from Longboard Pharmaceuticals as its price is falling. LBPH shares are trading up $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Longboard Pharmaceuticals? A short squeeze for Longboard Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LBPH, which in turn drives the price of the stock up even further. How often is Longboard Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LBPH, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies: SCTL Short Interest PTCT Short Interest XENE Short Interest IDYA Short Interest MOR Short Interest MLTX Short Interest RNA Short Interest DYN Short Interest AGIO Short Interest TGTX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LBPH) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredAvoid These AI Stocks Like the Plague...Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh co...Weiss Ratings | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longboard Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longboard Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.